Yuhan Corporation

₩80,400As of Sun 8 Nov 2026, 12:00 UTC
KRX:000100Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR 11.71%
Div yield 0.75%
ROE 9.51%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.39
PE TTM 25.61
TSR TTM (31.50%)
Mkt cap ₩5.996T
ROIC 4.36%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩101,325
26.03%
(27.42%)
Hold 1|11|9|12|1
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
1,046
1,021
1,098
1,121
7.25%
9.14%
18.53%
14.72%
Revenue₩B
285.6
279.5
275.3
281.0
7.62%
0.79%
0.64%
(2.00%)
Peers (US$4.421B)
Cap (US$)
PE
4.369B
27.31x
1.179B
—
Capital
TTM
5Y
10Y
Leveragex
1.566
0.019
0.017
EBIT/Intx
0.573
0.721
0.536
Own earn%
144.03
(172.44)
(172.28)
Sh yield%
35.96
18.79
19.54
Owners
Insiders/Inst%
8.25
21.64
Short interest%
0.58
SBC / revenue%
4.54
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
30–34
$1 testx
−0.1
Incr. ROIC%
14